IIS
REGN icon

Ignis Investment Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Ignis Investment Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$365M Buy
131,513
+35,281
+37% +$10.5M 1.22% 30
2014
Q1 		$289M Buy
+96,232
New +$29.6M 1.01% 43

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ignis Investment Services's REGN Position: Q2 2014 in Review

Ignis Investment Services increased its Regeneron Pharmaceuticals (REGN) stake by 37% in Q2 2014, buying an estimated $10.5M and bringing the position to 131,513 shares worth $365M. The position accounts for 1.22% of the portfolio, ranked #30.

Ignis Investment Services first reported a position in REGN in Q1 2014 and has held it in 2 quarters since. 447 funds tracked by Wall St. Rank hold REGN as of Q2 2014.

  • Ignis Investment Services held 131,513 shares of Regeneron Pharmaceuticals worth $365M as of Q2 2014.
  • Ignis Investment Services bought 35,281 Regeneron Pharmaceuticals shares in Q2 2014, an estimated $10.5M.
  • Regeneron Pharmaceuticals made up 1.22% of Ignis Investment Services's portfolio in Q2 2014, its #30 holding.
  • Ignis Investment Services first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 2 quarters since.
  • 447 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2014.

Based on Ignis Investment Services's 13F filing for Q2 2014, filed 15 Aug 2014.